3-[1-(2,3,5-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-OXO]-1H-1,5-BENZODIAZEPINE
Compound with spectra: 1 NMR
![3-[1-(2,3,5-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-OXO]-1H-1,5-BENZODIAZEPINE](/api/compound/KA5rccvX1nN.png?ph=true&h=300&w=458 "3-[1-(2,3,5-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-OXO]-1H-1,5-BENZODIAZEPINE")
| SpectraBase Compound ID | KA5rccvX1nN |
|---|---|
| InChI | InChI=1S/C36H28N2O8/c39-30(26-20-37-27-18-10-11-19-28(27)38-21-26)32-33(46-36(42)25-16-8-3-9-17-25)31(45-35(41)24-14-6-2-7-15-24)29(44-32)22-43-34(40)23-12-4-1-5-13-23/h1-21,29,31-33,37H,22H2/t29-,31-,32+,33-/m1/s1 |
| InChIKey | LQVIHEAMJIKMKP-WPXCQFTPSA-N |
| Mol Weight | 616.6 g/mol |
| Molecular Formula | C36H28N2O8 |
| Exact Mass | 616.184566 g/mol |
| Enantiomer InChIKey | LQVIHEAMJIKMKP-VDYOSWSPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(4-HYDROXY-3-NITROPHENYL)-ETHYL-DECA-O-BENZOYL-beta-MALTOTRIOSIDE
(2S,3R,5R)-3-AZIDO-2-BENZOYLOXY-5-(2',3',5'-TRI-O-BENZOYL-ALPHA-D-ARABINOFURANOSYLOXY)-CYCLOHEXANONE-O-BENZYL-OXIME
O-(2-NAPHTHOYL)-C-(2,3,4,6-TETRA-O-BENZOYL-BETA-D-GLUCOPYRANOSYL)-FORMAMIDOXIME
2,3,4,6-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSYL-(1->4)-2,3,6-TRI-O-BENZOYL-ALPHA-D-GALACTOPYRANOSYL-BROMIDE
6-HYDROXY-6-(2,3,5-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-PYRAN-3-(2H,6H)-SEMICARBAZONE
OCTA-O-(3-BROMO)-BENZOYL-ALPHA-LACTOPYRANOSIDE
PHENYL-2,3,4,6-TETRA-O-BENZOYL-BETA-D-GLUCOPYRANOSYL-(1->6)-2,3,4-TRI-O-BENZOYL-BETA-D-GLUCOPYRANOSYL-(1->6)-1-THIO-BETA-D-GLUCOPYRANOSIDE
1-(3,5-DI-O-BENZOYL-2-O-PHENOXYTHIO-CARBONYL-BETA-D-XYLOFURANOSYL)-URACILE
ALPHA-BISABOLOL-2,3,4,6-TETRA-O-BENZOYL-BETA-D-GLUCOPYRANOSIDE
2,3,5,6-TETRA-O-BENZOYL-BETA-D-GALACTOFURANOSYL-(1->5)-2,6-DI-O-PIVALOYL-D-GALACTONO-1,4-LACTONE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of 2-Imino-3-[1-(b-D-ribofuranosyl)oxo]-1H,5H-1,5-benzodiazepine through Condensation of o-Phenylenediamine with Formylisoxazole Glycoside | HETEROCYCLES | 1999 |